QT Sense announced it has closed a €4 million investment round to accelerate development and commercialization of its quantum sensing platform, which the company is positioning for drug discovery and spatial biology use cases.
In a LinkedIn post, the Netherlands-based company framed the raise as more than a financing event, describing it as a milestone in building toward what it called a “quantum future” for life sciences. QT Sense emphasized that the round is intended to accelerate its path from technical progress to broader market adoption, and it used the announcement to thank investors, partners, and supporters for helping it scale faster.
The company said Cottonwood Technology Fund led the investment, with QDNL Participations also participating. QT Sense characterized the backing as both a vote of confidence and continued support, suggesting the investors are aligned with the company’s long-term vision and its near-term commercialization priorities.
QT Sense said the proceeds will fund what it described as an “AAA strategy,” which it outlined as a dual push: accelerating user adoption in pharma while deepening the platform’s capabilities and scaling its ability to deliver at production quality. In practical terms, the strategy signals a shift from pilots and early engagement to repeatable customer deployments, while simultaneously investing in the engineering and manufacturing readiness required to support larger-scale usage.
The company also linked the funding round to what it described as a larger market opportunity. QT Sense said it is building a precision technology platform designed to unlock a multi-billion-euro opportunity in drug discovery, citing the industry’s demand for tools that deliver more accurate biological insights and better decision-making earlier in the R&D pipeline.
By positioning quantum sensing as an enabling layer for next-generation discovery and spatial biology workflows, the company is effectively arguing that its approach can help expand what is measurable and actionable in complex biological systems.
